Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Neuroblastoma
Drug:
melphalan
(
Alkylating agent
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A1 - Approval
Source:
European Medicines Agency
Published date:
11/25/2020
Excerpt:
Phelinun is a cancer medicine for treating patients with...Childhood neuroblastoma, a cancer of nerve cells in different parts of the body...
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login